Refine by
641 results found
-
Congressional Testimony on Mental Health Funding
Hannah Wesolowski’s congressional testimony, on behalf of NAMI, to the Senate Labor-HHS-Education Appropriations Subcommittee on NAMI’s FY 2024 appropriations priorities. -
Letter to FDA Commissioner & HHS Secretary on Research and Treatment Innovation
Letter to HHS Secretary Becerra and FDA Commissioner Califf urging the Federal Drug Administration FDA to reissue its ban of electrical stimulation devices used to treat self-injurious or aggressive behavior. -
Letter to Congressional Committee Leadership on Mental Health Funding
Letter to Chairwoman Murray detailing NAMI’s appropriations requests for FY2024 and urging the continued support of mental health as a national priority. -
Statement on Health Coverage
Statement in response to the ruling in the Braidwood versus Becerra case, which threatens coverage of U.S. Preventive Services Task Force recommended preventive services without cost sharing as required under the Affordable Care Act. -
Congressional Testimony on Mental Health Funding
Hannah Wesoloski’s Congressional testimony, on behalf of NAMI, to the House Labor-HHS-Education Appropriations Subcommittee on NAMI’s FY 2024 appropriations priorities. -
Letter to Congressional Committee Leadership on Mental Health Workforce
Letter to Senate HELP Committee leadership in response to the request for information (RFI) on the health care workforce shortage. -
Letter to Members of Congress on Health Coverage
Letter to Members of Congress in opposition to S.184 and H.R. 277 – the Regulations from the Executive in Need of Scrutiny Act of 2023 (REINS Act). -
Regulatory Comment to the Office of Science and Technology Policy on Criminal Justice and Research and Treatment Innovation
Regulatory comment to White House Office of Science & Technology Policy in response to the RFI on “Advancing Effective, Accountable Policing and Criminal Justice Practices to Enhance Public Trust and Public Safety.” -
Regulatory Comment to CMS Administrator & HHS Secretary on Health Coverage
Regulatory comments to HHS Secretary Becerra and CMS Administrator Brooks-LaSure in response to the Advancing Interoperability and Improving Prior Authorization Proposed Rule. -
Statement on Medicaid
Statement in support of federal and state policies that ensure those who remain eligible for Medicaid and CHIP understand this process and successfully reenroll, while those who are no longer eligible transition to other forms of quality, affordable healthcare coverage.